ONGLYZA 2.5 mg/1

Onglyza 2.5 mg is a film-coated tablet containing saxagliptin, used to manage type 2 diabetes. This oral medication helps control blood sugar levels when combined with diet and exercise.

Onglyza 2.5 mg is primarily used to manage type 2 diabetes in adults. It works by increasing the levels of incretin hormones, which help the pancreas release insulin. This medication is often prescribed alongside diet and exercise to improve glycemic control. People often ask, 'What is Onglyza used for?' and the answer is that it is designed to assist in the management of blood sugar levels in individuals with type 2 diabetes.

Common effects of Onglyza 2.5 mg may include headache, upper respiratory tract infection, and urinary tract infection. Some users might experience nausea or dizziness. It is important to note that individual responses to the medication can vary.

Onglyza 2.5 mg should be handled with care. It is essential to follow the advice of a healthcare provider regarding its use. Patients with a history of pancreatitis, kidney problems, or allergic reactions to similar medications should discuss these conditions with their doctor before starting Onglyza.

Onglyza 2.5 mg may interact with certain medications, including those metabolized by the liver enzyme CYP3A4/5. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.